 CureVac BV NASDAQ: CVAC shares are trading lower after the company and Bayer reportedly terminated their vaccine manufacturing partnership. More news came around 1:20 pm EDT after an SEC filing showed that dievini Hopp BioTech holding, which holds roughly 42 of outstanding CureVac shares, plans to sell some of its shares. 